Effect of yohimbine on brain monoamines: an in vivo study

J Neural Transm Park Dis Dement Sect. 1991;3(2):81-7. doi: 10.1007/BF02260883.

Abstract

Following the administration of yohimbine, an alpha 2-adrenoreceptor antagonist, the levels of norepinephrine (NE), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5HIAA) increased significantly in the lateral ventricular fluid of rats. These increases were abolished when animals were pretreated with alpha-methyl-para-tyrosine or reserpine. Dopamine (DA) was not detected in ventricular fluid either before or after yohimbine administration. Yohimbine administration did, however, increase intracellular DA levels in the corpus striatum. These findings indicate that yohimbine promotes NE and DA release in the brain and suggest that it also modifies the activity of the serotonin system.

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Biogenic Amines / metabolism*
  • Brain / drug effects
  • Brain / metabolism*
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / metabolism
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Dopamine / metabolism
  • Homovanillic Acid / metabolism
  • Hydroxyindoleacetic Acid / metabolism
  • Kinetics
  • Male
  • Methyltyrosines / pharmacology
  • Norepinephrine / cerebrospinal fluid
  • Norepinephrine / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Reserpine / pharmacology
  • Tyrosine 3-Monooxygenase / antagonists & inhibitors
  • Yohimbine / pharmacology*
  • alpha-Methyltyrosine

Substances

  • Biogenic Amines
  • Methyltyrosines
  • 3,4-Dihydroxyphenylacetic Acid
  • Yohimbine
  • Hydroxyindoleacetic Acid
  • alpha-Methyltyrosine
  • Reserpine
  • Tyrosine 3-Monooxygenase
  • Dopamine
  • Norepinephrine
  • Homovanillic Acid